Clinical Trial Update: A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants [Phase 1]

View source ↗

Summary

Completed Phase 1 study evaluating the effect of etavopivat on other drugs in healthy participants, sponsored by Novo Nordisk A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Thalassemia

Drugs mentioned

• Etavopivat (Etavopivat)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers Sickle Cell Disease, Thalassemia | Phase 1 | Status: COMPLETED